Abstract:OBJECTIVE:To study the effects of RNA interference (RNAi)-mediated insulin-like growth factor I receptor (IGF-IR) gene silencing on human lung cancer cells. METHODS:Plasmids expressing IGF-IR shRNA1 and IGF-IR shRNA2 were constructed. Human non-small cell lung cancer cells of the line A549 were cultured and transfected with sequence-specific shRNA. RT-PCR was used to monitor the IGF-IR mRNA expression. Western blotting was used to detect the expression of IGF-IR, bcl-2 and caspase-3, associated with apoptosis, and IGF-IR signaling pathways-associated proteins, total and phospho-ERK1/2 and Akt. MTT assay and flow cytometry were used to examine the cell activity and cell cycle. Twelve nude mice were injected subcutaneously with A549 cells, 20 days later the mice were randomly divided into 3 groups to be injected into the tumor with IGF-IR, PBS, or blank plasmid respectively 4 times with the interval of 5 days. Five days after the 4th injection the mice were killed and the tumors were taken out. TUNNEL assay was used to detect the apoptotic cell in the tumor. RESULTS:RT-PCR showed that the IGF-IR mRNA expression level of the A549 cells transfected with IGF-IR shRNA1 was only 24% +/- 4% that of the A549 cells transfected with blank plasmid (P < 0.05); however, the IGF-IR mRNA expression level of the A549 cells transfected with IGF-IR shRNA2 was 78% +/- 5% that of the A549 cells transfected with blank plasmid (P > 0.05). The IGF-IR protein expression level of the A549 cells of the IGF-IR shRNA1 group was only 10.2% +/- 2.8% that of the A549 cells of the blank plasmid group (P < 0.05). Western blotting showed that the protein expression levels of bcl-2 and caspase-3p20 of the A549 cells of the IGF-IR shRNA1 group were 46% +/- 6% and 156% +/- 8% those of the negative controls (both P < 0.05); however, the protein expression levels of bcl-2 and caspase-3p20 of the A549 cells of the IGF-IR shRNA2 group were not different from those of the negative control cells. The Akt kinase and ERK phosphorylation levels of the A549 cells of the IGF-IR shRNA1 group were 10% and 36% +/- 3% those of the negative control cells respectively (both P < 0.05). Since 48h after the transfection the active cell number of the IGF-IR shRNA1 group was 64% +/- 7% that of the negative group (P < 0.05), and this decrease effect lasted to 72 h after (67% +/- 6% that of the negative cells, P < 0.05). 48 h after the transfection the percentage of cells at G(0)/G(1) phase of the IGF-IR shRNA1 group was 77.5%, significantly higher than that of the negative control group, and the percentages of the cells at S and G(2)/M phases of the IGF-IR shRNA1 group were 15.7% and 7.3% respectively, both significantly lower than those of the negative control group (23.0% and 29.9% respectively). Since the second injection the tumor size of the mice of IGF-IR shRNA group was 40% - 50% that of the PBS group (P < 0.05), and the tumor size of the mice of the PBS group was 90% that of the control group. TUNNEL assay showed that the number of apoptotic cells in the tumors of the IGF-IR shRNA1 group mice was 118 +/- 8/high power, significantly higher than that of the control group (70 +/- 9, P < 0.05). CONCLUSION:RNAi technique effectively inhibits the expression of IGF-IR, thus decreasing the NSCLC cell proliferation inducing apoptosis and inhibiting the tumor growth.

Inhibition of human lung carcinoma H460 cell proliferation by siRNA-mediated MIF knockdown

Functional Disruption of Macrophage Migration Inhibitory Factor (MIF) Suppresses Proliferation of Human H460 Lung Cancer Cells by Caspase-Dependent Apoptosis

siRNA-mediated silencing of BC047440 gene inhibits proliferation of human HepG2 cell

Effect and Molecular Mechanism of Mir-146A on Proliferation of Lung Cancer Cells by Targeting and Regulating MIF Gene

Influences of Over-Expression of VEGF-C and Its Inhibition on Biological Characteristics of NCI-H446 Human Small-Cell Lung Cancer Cells

[The Inhibitory Effects of Sirna Expression Vector on Cell Proliferation and Expression of Hnrnpb1 Gene in Lung Cancer A549 Cells].

Inhibiting the proliferation of osteosarcoma 143B cell by blocking the MIF gene with siRNA

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

Downregulation of Hnrnp K by Rnai Inhibits Growth of Human Lung Carcinoma Cells

Effect of mTOR gene inhibition by siRNA on proliferation and apoptosis of human hepatoma HepG2 cells

The effect of the small interfering RNAs for macrophage migration inhibitory factor on apoptosis of colorectal cancer cell line

Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer

The Expression Inhibition of HnRNP B1 in Lung Cell Line A549 by Small Interfering RNA

A global genomic view of MIF knockdown-mediated cell cycle arrest.

Macrophage Migration Inhibitory Factor Sirna Inhibits Hepatic Metastases of Colorectal Cancer Cells.

[Shrna-Mediated Insulin-Like Growth Factor I Receptor Gene Silencing Inhibits Cell Proliferation, Induces Cell Apoptosis, and Suppresses Tumor Growth in Non-Small Cell Lung Cancer: in Vitro and in Vivo Experiments].

MicroRNA-221 Promotes Human Non-Small Cell Lung Cancer Cell H460 Growth.

Knockdown of FoxM1 by Sirna Interference Decreases Cell Proliferation, Induces Cell Cycle Arrest and Inhibits Cell Invasion in MHCC-97H Cells in Vitro

Macrophage Migration Inhibitory Factor As a Potential Prognostic Factor in Gastric Cancer.

Inhibition of MicroRNA-21-5p Promotes the Radiation Sensitivity of Non-Small Cell Lung Cancer Through HMSH2

Effects of HIF-1α gene knock-down on proliferation of and VEGF expression in human colon carcinoma SW480 cells